Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Silo Pharma ( (SILO) ) is now available.
On August 4, 2025, Silo Pharma‘s Board of Directors approved the establishment of a cryptocurrency advisory board as part of its new cryptocurrency treasury strategy, appointing Corwin Yu as the initial member. The company aims to focus on digital assets like Bitcoin, Ethereum, and Solana, leveraging staking for yield generation and capital preservation. This move is expected to create long-term value for stockholders and is complemented by the acquisition of AI-powered market intelligence technology.
More about Silo Pharma
Silo Pharma is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company. Its therapeutic focus is on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system diseases. The company’s portfolio includes innovative programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer’s disease and multiple sclerosis.
Average Trading Volume: 1,139,722
Technical Sentiment Signal: Sell
Current Market Cap: $5.23M
Find detailed analytics on SILO stock on TipRanks’ Stock Analysis page.